Cargando…
Targeting FoxO1 with AS1842856 Suppresses Adipogenesis
Hyperplasia (i.e., increased adipogenesis) contributes to excess adiposity, the hallmark of obesity that can trigger metabolic complications. As FoxO1 has been implicated in adipogenic regulation, we investigated the kinetics of FoxO1 activation during adipocyte differentiation, and tested the effec...
Autores principales: | Zou, Peng, Liu, Longhua, Zheng, Louise, Liu, Lu, Stoneman, Rebecca E, Cho, Alicia, Emery, Ashley, Gilbert, Elizabeth R, Cheng, Zhiyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613185/ https://www.ncbi.nlm.nih.gov/pubmed/25483084 http://dx.doi.org/10.4161/15384101.2014.965977 |
Ejemplares similares
-
The FOXO1 inhibitor AS1842856 triggers apoptosis in glioblastoma multiforme and basal‐like breast cancer cells
por: Flores, David, et al.
Publicado: (2023) -
FoxO transcription factors in mitochondrial homeostasis
por: Cheng, Zhiyong
Publicado: (2022) -
FoxO1 interacts with transcription factor EB and differentially regulates mitochondrial
uncoupling proteins via autophagy in adipocytes
por: Liu, Longhua, et al.
Publicado: (2016) -
FoxO3 suppresses Myc-driven lymphomagenesis
por: Vandenberg, C J, et al.
Publicado: (2016) -
Suppression of FoxO6 by lipopolysaccharide in aged rat liver
por: Kim, Dae Hyun, et al.
Publicado: (2015)